IMMUNITYBIO INC (IBRX)

US45256X1037 - Common Stock

7.65  -0.1 (-1.29%)

After market: 7.68 +0.03 (+0.39%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-3-31)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
301.00K622.00K240.00K930.00K610.00K
Minority Interest Expense
433.00K656.00K750.00K3.06M2.34M
Operating Expenses
345.29M361.99M350.86M331.21M210.83M
Research and Development
204.46M229.47M245.45M195.36M139.01M
Selling, General, and Administrative Expenses
138.83M130.52M103.51M135.86M71.82M
Operating Income
-344.99M-361.36M-350.62M-330.28M-210.22M
Interest Income/Expense
-189.05M-173.66M-63.77M-19.26M-5.78M
Other Income/Expense
-66.52M-47.98M-2.22M-300.00K630.00K
Non Recurring Items
N/A-886.00K-680.00K0.00-10.66M
Income Before Taxes
-601.44M-583.89M-417.29M-349.84M-226.03M
Income Tax
-40.00K-40.00K30.00K10.00K-1.85M
Net Income
-600.96M-583.20M-416.57M-346.79M-221.85M
EBITDA
-326.60M-342.85M-332.36M-316.04M-197.48M
 
Per Share Data
EPS Diluted Total Ops
-1.06-1.15-1.04-0.89-0.59
Non GAAP EPS
-1.06-1.13-1.05-0.89-0.89
 
Statistics
Profit Margin
-199655.48%-93761.41%-173570.83%-37289.25%-36368.85%
Operating Profit Margin
-114612.96%-58097.11%-146091.67%-35513.98%-34462.30%

All data in USD

Charts